These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 8576551)

  • 41. [Muscular biopsy in ceroid lipofuscinosis: 3 case reports of juvenile form].
    Pego R; Amigo MC; Escriche D; Romero J; Navarro C
    Rev Neurol; 1995; 23(121):627-31. PubMed ID: 8597983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuronal ceroid-lipofuscinosis--late-infantile or Jansky-Bielschowsky type--revisited.
    Goebel HH; Gerhard L; Kominami E; Haltia M
    Brain Pathol; 1996 Jul; 6(3):225-8. PubMed ID: 8864279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mitochondrial abnormalities in CLN2 and CLN3 forms of Batten disease.
    Dawson G; Kilkus J; Siakotos AN; Singh I
    Mol Chem Neuropathol; 1996; 29(2-3):227-35. PubMed ID: 8971698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electron microscopic studies on skin and lymphocytes in early juvenile neuronal ceroid-lipofuscinosis.
    Kimura S; Goebel HH
    Brain Dev; 1987; 9(6):576-80. PubMed ID: 3445918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dolichols in brain and urinary sediment in neuronal ceroid lipofuscinosis.
    Wolfe LS; Ng Ying Kin NM; Palo J; Haltia M
    Neurology; 1983 Jan; 33(1):103-6. PubMed ID: 6681549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Batten disease (Neuronal ceroid lipofuscinoses)--accumulation of ATP synthase subunit c caused by the delay of lysosomal degradation].
    Ezaki J; Kominami E
    Nihon Rinsho; 1995 Dec; 53(12):3055-61. PubMed ID: 8577058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations.
    Wisniewski KE; Kaczmarski A; Kida E; Connell F; Kaczmarski W; Michalewski MP; Moroziewicz DN; Zhong N
    Mol Genet Metab; 1999 Apr; 66(4):248-52. PubMed ID: 10191110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).
    Hawkins-Salsbury JA; Cooper JD; Sands MS
    Biochim Biophys Acta; 2013 Nov; 1832(11):1906-9. PubMed ID: 23747979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinico-pathological manifestations of variant late infantile neuronal ceroid lipofuscinosis (vLINCL) caused by a novel mutation in MFSD8 gene.
    Mandel H; Cohen Katsanelson K; Khayat M; Chervinsky I; Vladovski E; Iancu TC; Indelman M; Horovitz Y; Sprecher E; Shalev SA; Spiegel R
    Eur J Med Genet; 2014; 57(11-12):607-12. PubMed ID: 25270050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coding sequence and exon/intron organization of the canine CLN3 (Batten disease) gene and its exclusion as the locus for ceroid-lipofuscinosis in English setter dogs.
    Shibuya H; Liu PC; Katz ML; Siakotos AN; Nonneman DJ; Johnson GS
    J Neurosci Res; 1998 May; 52(3):268-75. PubMed ID: 9590435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prenatal ultrastructural diagnosis in the neuronal ceroid-lipofuscinoses.
    Goebel HH
    Pathol Res Pract; 1994 Aug; 190(7):728-33. PubMed ID: 7808971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pheno/genotypic correlations of neuronal ceroid lipofuscinoses.
    Wisniewski KE; Zhong N; Philippart M
    Neurology; 2001 Aug; 57(4):576-81. PubMed ID: 11548735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variant late infantile neuronal ceroid lipofuscinosis because of CLN1 mutations.
    Simonati A; Tessa A; Bernardina BD; Biancheri R; Veneselli E; Tozzi G; Bonsignore M; Grosso S; Piemonte F; Santorelli FM
    Pediatr Neurol; 2009 Apr; 40(4):271-6. PubMed ID: 19302939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Tripeptidyl peptidase 1 in patients with late infantile neuronal ceroid lipofuscinosis].
    Contreras LM; Luengo WD; Zerpa N; Hernández JC; Chávez CJ; Ferrer SG
    An Pediatr (Barc); 2012 Mar; 76(3):148-52. PubMed ID: 22100780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrastructure and visceral distribution of lipopigments in infantile neuronal ceroid-lipofuscinosis.
    Siegismund G; Goebel HH; Löblich HJ
    Pathol Res Pract; 1982 Dec; 175(4):335-47. PubMed ID: 7167408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late-infantile neuronal ceroid lipofuscinosis (CLN2/Jansky-Bielschowsky type) in Oman.
    Koul R; Al-Futaisi A; Ganesh A; Rangnath Bushnarmuth S
    J Child Neurol; 2007 May; 22(5):555-9. PubMed ID: 17690061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinico-investigative profile of infantile and late-infantile neuronal ceroid lipofuscinoses.
    Kamate M; Prashanth GP; Hattiholi V
    Neurol India; 2012; 60(3):316-20. PubMed ID: 22824694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Superoxide dismutase isoenzymes in cerebrospinal fluid and plasma from patients with neuronal ceroid-lipofuscinoses.
    Marklund SL; Heiskala H; Westermarck T; Santavuori P
    Clin Sci (Lond); 1986 Jul; 71(1):57-60. PubMed ID: 3709075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurological progress. The neuronal ceroid lipofuscinoses: a review.
    Boustany RM; Kolodny EH
    Rev Neurol (Paris); 1989; 145(2):105-10. PubMed ID: 2657976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study.
    Tokola AM; Salli EK; Åberg LE; Autti TH
    Pediatr Neurol; 2014 Feb; 50(2):158-63. PubMed ID: 24411222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.